Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
41 studies found for:    " January 08, 2013":" February 07, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Active, not recruiting An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
2 Active, not recruiting
Has Results
Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: E/C/F/TAF;   Drug: E/C/F/TDF;   Drug: E/C/F/TDF Placebo;   Drug: E/C/F/TAF Placebo
3 Completed Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).
Condition: HIV Infection
Intervention: Drug: FTC/TDF (Truvada®)
4 Completed Feasibility of Using a Structured Daily Diary
Condition: HIV Infection
Intervention: Behavioral: Structured daily diary
5 Active, not recruiting Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: NYVAC-HIV-PT1 vaccine;   Biological: NYVAC-HIV-PT4 vaccine;   Biological: Placebo for DNA-HIV-PT123 vaccine;   Biological: Placebo for NYVAC-HIV-PT1 vaccine;   Biological: Placebo for NYVAC-HIV-PT4 vaccine
6 Enrolling by invitation IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children
Conditions: HIV Positive;   Malnourished
Intervention: Drug: ZDV+3TC+LPV/r
7 Recruiting CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
Condition: HIV
Intervention: Behavioral: CVCTPLUS
8 Completed Effects of Newly-Initiated QUAD Therapy on Aortic/Coronary Inflammation in ART-Naïve Infected Patients
Condition: HIV
Intervention:
9 Completed An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Continued Access Arm
10 Recruiting Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at High Risk of Acquiring HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: Raltegravir
11 Active, not recruiting Music for Health Project
Condition: Human Immunodeficiency Virus
Intervention: Behavioral: mobile phone application
12 Active, not recruiting Living Well Project for Persons With AIDS
Condition: Acquired Immunodeficiency Syndrome (AIDS)
Interventions: Behavioral: AIDS EPC Package plus MI;   Other: Standard of Care (SOC)
13 Recruiting Pediatric HIV Disclosure Intervention
Condition: Paediatric HIV Diagnosis Disclosure
Intervention: Behavioral: Cognitive behavioral intervention to support pediatric HIV disclosure
14 Recruiting DRV/r + RPV QD: Efficacy and Toxicity Reduction
Condition: Human Immunodeficiency Virus
Interventions: Drug: RPV + DRV/r;   Drug: continue the PI/r-containing HAART.
15 Completed Home-based Partner Education and Testing (HOPE) Study
Condition: HIV
Interventions: Behavioral: HOPE Intervention;   Behavioral: INVITE Intervention
16 Completed PK TDF in Thai HIV-infected Children
Condition: HIV
Interventions: Drug: TDF (Tenofovir);   Drug: Efavirenz;   Drug: lopinavir/ritonavir, atazanavir/ritonavir
17 Active, not recruiting Redirected MazF‐CD4 Autologous T Cells for HIV Gene Therapy
Condition: HIV
Intervention: Genetic: Autologous CD4+ T cells genetically modified with a retroviral vector expressing the MazF endoribonuclease gene (MazF‐T), given via intravenous infusion.
18 Completed The Effect of Antacids and Multivitamins on Raltegravir
Condition: HIV
Interventions: Dietary Supplement: Multivitamins;   Dietary Supplement: Sodium bicarbonate;   Drug: Maalox Plus extra;   Drug: Raltegravir 400 mg
19 Completed Virological and Immunological Safety of a Dose Reduction Strategy Antiretroviral Regimen With Efavirenz / Tenofovir / Emtricitabine
Condition: HIV
Intervention: Drug: ATRIPLA
20 Active, not recruiting The HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial
Condition: Rapid HIV Screening
Interventions: Other: A: Nontargeted rapid HIV screening;   Other: B: Enhanced targeted rapid HIV screening;   Other: C: Traditional targeted rapid HIV screening

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.